Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
10/2017 not set
Neviah Genomics
Neviah Genomics Overview
Neviah Genomics is the inventor and developer of PropheTox, a drug toxicity screening service. Based on the mathematical analysis of cell behavior following exposure to multiple toxic and non-toxic compounds, PropheTox's innovatve assay design and optimized decision support algorithms allow the detection of low-dose, chronic toxic effects. The predictive quality of the PropheTox technology is developed through an iterative process involving toxicity assays, machine learning, and prior biological knowledge. The predictor is based on non-trivial analysis of expression data from experiments exposing primary liver cells to compounds with known toxicity, and representing a wide variety of liver toxicity pathways.
Neviah Genomics Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 12, 2015
www.businesswire.com
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing
undefined
View other companies you might be interested in
Neviah Genomics Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.